CYLD and adult T-cell leukemia/lymphoma: While there are limitations with the pharmacological and dominant-negative approaches used in this study, nonetheless the observations strongly suggest that phosphorylation of CYLD is a mechanism used by ATLL cells to suppress this tumor suppressor and maintain tumor cell survival.